What is your approach to managing patients with medically inoperable early stage endometrial adenocarcinoma who also cannot tolerate intracavitary brachytherapy (Rotte-Y, etc) as boost?

Answer from: Radiation Oncologist at Academic Institution

The curative-intent treatment of medically inoperable patients can be clinically challenging. Treatment is best individualized, taking into account their comorbidities, severity of disease, and other factors. Inoperability (unsuitable for hysterectomy) is largely due to serious medical comorbidit...

Comments

Radiation Oncologist at John H. Stroger Hospital of Cook County
Thank you, this was a very helpful and thoughtful ...

Radiation Oncologist at Maimonides Medical Center
Would you ever consider the addition of concurrent...

Radiation Oncologist at University of Kentucky
I think that this situation is a bit different fro...

Radiation Oncologist at Gulf International Cancer Center
Agree. We deliver HDR brachy, with thin tandem and...

Radiation Oncologist at Maimonides Medical Center
Thanks for the response

Radiation Oncologist

@Marcus E. Randall has a very comprehensive answer and I agree with it. It is almost always possible to perform brachytherapy. Patients can be hospitalized and treated BID to avoid having to place the applicator more than once. If I elect to offer radiation to a patient who cannot undergo brac...

Answer from: Radiation Oncologist at Community Practice

We don’t need a Rotte-Y applicator in most in the era of image based approaches.Research here and here.

Please select the option that best describes you:

What is your approach to managing patients with medically inoperable early stage endometrial adenocarcinoma who also cannot tolerate intracavitary brachytherapy (Rotte-Y, etc) as boost?

Related Questions